{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:10:55Z","timestamp":1791943855063,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.bcmd.2014.01.005","type":"journal-article","created":{"date-parts":[[2014,2,9]],"date-time":"2014-02-09T00:16:28Z","timestamp":1391904988000},"page":"30-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Gaucher disease: Plasmalogen levels in relation to primary lipid abnormalities and oxidative stress"],"prefix":"10.1016","volume":"53","author":[{"given":"Marina","family":"Moraitou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Dimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Monopolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Michelakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2014.01.005_bb0005","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bcmd.2014.01.005_bb0010","series-title":"Bailliere's Clinical Haematology","first-page":"691","article-title":"Plasma and metabolic abnormalities in Gaucher disease","author":"Aerts","year":"1997"},{"key":"10.1016\/j.bcmd.2014.01.005_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids and inhibodies","volume":"34","author":"Aerts","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcmd.2008.03.007","article-title":"Plasmalogen levels in Gaucher disease","volume":"41","author":"Moraitou","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0025","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","article-title":"Functions of plasmalogen lipids in health and disease","volume":"1822","author":"Braverman","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2014.01.005_bb0030","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbamcr.2006.08.038","article-title":"Tracking down plasmalogen functions","volume":"1763","author":"Gorgas","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2014.01.005_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0009-8981(86)90014-8","article-title":"Membrane lipid peroxidation in erythrocytes of the newborn","volume":"161","author":"Jain","year":"1986","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcmd.2014.01.005_bb0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbalip.2007.11.004","article-title":"Plasma glycosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention","volume":"1781","author":"Groener","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2014.01.005_bb0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in type 1 Gaucher disease patients: correlations with storage cells markers, clinical manifestations and response to therapy","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.01.005_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1432-1033.2003.03356.x","article-title":"Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide","volume":"270","author":"Latorre","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0006-291X(73)90916-9","article-title":"Deficiency of glucosylsphingosine: beta-glucosidase in Gaucher disease","volume":"54","author":"Rayhavan","year":"1973","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","article-title":"Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease","volume":"39","author":"Nilsson","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype","volume":"76","author":"Orvisky","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-2275(20)39839-4","article-title":"Krabbe disease: a galactosylsphingosine (psychosine) lipidosis","volume":"21","author":"Svennerholm","year":"1980","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0075","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriasylsphingosine is a hallmark of Fabry disease","volume":"108","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0080","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1471-4159.1992.tb08460.x","article-title":"Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses","volume":"59","author":"Kobayashi","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0085","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jnr.20529","article-title":"Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease","volume":"80","author":"Khan","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0090","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/hmg\/ddg236","article-title":"Impaired neuronal migration and endochondral ossification in PEX7 knockout mice: a model for rhizomelic chondrodysplasia punctata","volume":"12","author":"Brites","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0095","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcp.21023","article-title":"Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stress","volume":"212","author":"Deganuto","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cca.2005.07.022","article-title":"Blood oxidative stress markers in Gaucher disease patients","volume":"364","author":"Roversi","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcmd.2014.01.005_bb0110","article-title":"Oxidative stress, trace elements and circulating microparticles in patients with Gaucher disease before and after enzyme replacement therapy","author":"Zahran","year":"2013","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2014.01.005_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2011.06.008","article-title":"Plasmalogens the neglected regulatory and scavenging lipid species","author":"Wallner","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bcmd.2014.01.005_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj3400377","article-title":"Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids","volume":"340","author":"Hahnel","year":"1999","journal-title":"Biochem. J."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:30:24Z","timestamp":1761049824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979614000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1079979614000060"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.01.005","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaucher disease: Plasmalogen levels in relation to primary lipid abnormalities and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}